{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:30:24Z","timestamp":1772620224446,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T00:00:00Z","timestamp":1598745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T00:00:00Z","timestamp":1598745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1165119N"],"award-info":[{"award-number":["1165119N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1S46219N"],"award-info":[{"award-number":["1S46219N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["senior clinical investigatorship"],"award-info":[{"award-number":["senior clinical investigatorship"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["FWO-Odysseus grant No. G0F8516N"],"award-info":[{"award-number":["FWO-Odysseus grant No. G0F8516N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["FWO-Odysseus grant No. G0F8516N"],"award-info":[{"award-number":["FWO-Odysseus grant No. G0F8516N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders"},{"name":"ALS Liga Belgium"},{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","award":["ALS funds \u2018Een hart voor ALS\u2019"],"award-info":[{"award-number":["ALS funds \u2018Een hart voor ALS\u2019"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","award":["\u2018Laeversfonds voor ALS onderzoek'"],"award-info":[{"award-number":["\u2018Laeversfonds voor ALS onderzoek'"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","award":["\u2018Val\u00e9ry Perrier Race against ALS Fund\u2019"],"award-info":[{"award-number":["\u2018Val\u00e9ry Perrier Race against ALS Fund\u2019"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","award":["C14-17-107"],"award-info":[{"award-number":["C14-17-107"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","award":["C14-17-107"],"award-info":[{"award-number":["C14-17-107"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vlaamse Impulsfinanciering voor Netwerken voor Dementie Onderzoek","award":["VIND, IWT 135043"],"award-info":[{"award-number":["VIND, IWT 135043"]}]},{"name":"Vlaamse Impulsfinanciering voor Netwerken voor Dementie Onderzoek","award":["VIND, IWT 135043"],"award-info":[{"award-number":["VIND, IWT 135043"]}]},{"name":"Mady Browaeys Fund for Research into Frontotemporal degeneration"},{"name":"German Federal Ministry of Education and Research","award":["FTLDc 01GI1007A"],"award-info":[{"award-number":["FTLDc 01GI1007A"]}]},{"name":"German Federal Ministry of Education and Research","award":["MND-Net 01GM1103A"],"award-info":[{"award-number":["MND-Net 01GM1103A"]}]},{"name":"German Research Foundation\/DFG","award":["SFB1279"],"award-info":[{"award-number":["SFB1279"]}]},{"DOI":"10.13039\/100009281","name":"Fondation Thierry Latran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EU Joint Programme-Neurodegenerative Diseases networks Genfi-Prox"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00401-020-02216-9","type":"journal-article","created":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T05:02:31Z","timestamp":1598763751000},"page":"777-781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dipeptide repeat protein and TDP-43 pathology along the hypothalamic\u2013pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases"],"prefix":"10.1007","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0545-8072","authenticated-orcid":false,"given":"Lieselot","family":"Dedeene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Van Schoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Ospitalieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Ronisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen H.","family":"Weishaupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert C.","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Scheuerle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Poesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-1075","authenticated-orcid":false,"given":"Dietmar Rudolf","family":"Thal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,30]]},"reference":[{"key":"2216_CR1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","volume":"77","author":"PEA Ash","year":"2013","unstructured":"Ash PEA, Bieniek KF, Gendron TF, Caulfield T, Lin W-L, DeJesus-Hernandez M et al (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS. Neuron 77:639\u2013646. https:\/\/doi.org\/10.1016\/j.neuron.2013.02.004","journal-title":"Neuron"},{"key":"2216_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","volume":"14","author":"R Balendra","year":"2018","unstructured":"Balendra R, Isaacs AM (2018) C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol 14:544\u2013558. https:\/\/doi.org\/10.1038\/s41582-018-0047-2","journal-title":"Nat Rev Neurol"},{"key":"2216_CR3","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/j.1468-1331.2006.01503.x","volume":"13","author":"E Bilic","year":"2006","unstructured":"Bilic E, Bilic E, Rudan I, Kusec V, Zurak N, Delimar D et al (2006) Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls. Eur J Neurol 13:1340\u20131345. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01503.x","journal-title":"Eur J Neurol"},{"key":"2216_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s40478-014-0171-1","volume":"2","author":"MD Cykowski","year":"2014","unstructured":"Cykowski MD, Takei H, Schulz PE, Appel SH, Powell SZ (2014) TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathol Commun 2:171. https:\/\/doi.org\/10.1186\/s40478-014-0171-1","journal-title":"Acta Neuropathol Commun"},{"key":"2216_CR5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/mds.26868","volume":"32","author":"E De Pablo-Fernandez","year":"2017","unstructured":"De Pablo-Fernandez E, Courtney R, Holton JL, Warner TT (2017) Hypothalamic \u03b1-synuclein and its relation to weight loss and autonomic symptoms in Parkinson\u2019s disease. Mov Disord 32:296\u2013298. https:\/\/doi.org\/10.1002\/mds.26868","journal-title":"Mov Disord"},{"key":"2216_CR6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00401-019-01996-z","volume":"137","author":"L Dedeene","year":"2019","unstructured":"Dedeene L, Van Schoor E, Race V, Moisse M, Vandenberghe R, Poesen K et al (2019) An ALS case with 38 (G4C2)-repeats in the C9orf72 gene shows TDP-43 and sparse dipeptide repeat protein pathology. Acta Neuropathol 137:855\u2013858. https:\/\/doi.org\/10.1007\/s00401-019-01996-z","journal-title":"Acta Neuropathol"},{"key":"2216_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s40478-019-0845-9","volume":"7","author":"L Dedeene","year":"2019","unstructured":"Dedeene L, Van Schoor E, Vandenberghe R, Van Damme P, Poesen K, Thal DR (2019) Circadian sleep\/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases. Acta Neuropathol Commun 7:189. https:\/\/doi.org\/10.1186\/s40478-019-0845-9","journal-title":"Acta Neuropathol Commun"},{"key":"2216_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245\u2013256. https:\/\/doi.org\/10.1016\/j.neuron.2011.09.011","journal-title":"Neuron"},{"key":"2216_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000074445","volume":"78","author":"JL Gonz\u00e1lez De Aguilar","year":"2003","unstructured":"Gonz\u00e1lez De Aguilar JL, Ren\u00e9 F, Dupuis L, Loeffler JP (2003) Neuroendocrinology of neurodegenerative diseases: insights from transgenic mouse models. Neuroendocrinology 78:244\u2013252. https:\/\/doi.org\/10.1159\/000074445","journal-title":"Neuroendocrinology"},{"key":"2216_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1440-1789.2011.01273.x","volume":"32","author":"T Homma","year":"2012","unstructured":"Homma T, Mochizuki Y, Mizutani T (2012) Phosphorylated \u03b1-synuclein immunoreactivity in the posterior pituitary lobe. Neuropathology 32:385\u2013389. https:\/\/doi.org\/10.1111\/j.1440-1789.2011.01273.x","journal-title":"Neuropathology"},{"key":"2216_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jamaneurol.2013.1933","volume":"70","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VMY et al (2013) Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol 70:462\u2013468. https:\/\/doi.org\/10.1001\/jamaneurol.2013.1933","journal-title":"JAMA Neurol"},{"key":"2216_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.cmet.2015.08.016","volume":"22","author":"M Ishii","year":"2015","unstructured":"Ishii M, Iadecola C (2015) Metabolic and non-cognitive manifestations of Alzheimers disease: the hypothalamus as both culprit and target of pathology. Cell Metab 22:761\u2013776. https:\/\/doi.org\/10.1016\/j.cmet.2015.08.016","journal-title":"Cell Metab"},{"key":"2216_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00401-013-1181-y","volume":"126","author":"IR MacKenzie","year":"2013","unstructured":"MacKenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K et al (2013) Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol 126:859\u2013879. https:\/\/doi.org\/10.1007\/s00401-013-1181-y","journal-title":"Acta Neuropathol"},{"key":"2216_CR14","doi-asserted-by":"publisher","first-page":"29282","DOI":"10.18632\/oncotarget.16502","volume":"8","author":"LB Mitrofanova","year":"2017","unstructured":"Mitrofanova LB, Konovalov PV, Krylova JS, Polyakova VO, Kvetnoy IM (2017) Plurihormonal cells of normal anterior pituitary: facts and conclusions. Oncotarget 8:29282\u201329299. https:\/\/doi.org\/10.18632\/oncotarget.16502","journal-title":"Oncotarget"},{"key":"2216_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1365-2265.2006.02609.x","volume":"65","author":"LL Morselli","year":"2006","unstructured":"Morselli LL, Bongioanni P, Genovesi M, Licitra R, Rossi B, Murri L et al (2006) Growth hormone secretion is impaired in amyotrophic lateral sclerosis. Clin Endocrinol (Oxf) 65:385\u2013388. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02609.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2216_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130\u2013133. https:\/\/doi.org\/10.1126\/science.1134108","journal-title":"Science"},{"key":"2216_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.psym.2019.11.002","volume":"61","author":"A Newhouse","year":"2020","unstructured":"Newhouse A, Chemali Z (2020) Neuroendocrine disturbances in neurodegenerative disorders: a scoping review. Psychosomatics 61:105\u2013115. https:\/\/doi.org\/10.1016\/j.psym.2019.11.002","journal-title":"Psychosomatics"},{"key":"2216_CR18","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1468-1331.2009.02896.x","volume":"17","author":"MT Pellecchia","year":"2010","unstructured":"Pellecchia MT, Pivonello R, Monsurr\u00f2 MR, Trojsi F, Longo K, Piccirillo G et al (2010) The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features. Eur J Neurol 17:666\u2013671. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02896.x","journal-title":"Eur J Neurol"},{"key":"2216_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00401-017-1793-8","volume":"135","author":"S Saberi","year":"2018","unstructured":"Saberi S, Stauffer JE, Jiang J, Garcia SD, Taylor AE, Schulte D et al (2018) Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol 135:459\u2013474. https:\/\/doi.org\/10.1007\/s00401-017-1793-8","journal-title":"Acta Neuropathol"},{"key":"2216_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00415-011-6146-2","volume":"259","author":"F Sacc\u00e0","year":"2012","unstructured":"Sacc\u00e0 F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Perrotta G et al (2012) A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. J Neurol 259:132\u2013138. https:\/\/doi.org\/10.1007\/s00415-011-6146-2","journal-title":"J Neurol"},{"key":"2216_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40478-018-0564-7","volume":"6","author":"N Sakae","year":"2018","unstructured":"Sakae N, Bieniek KF, Zhang YJ, Ross K, Gendron TF, Murray ME et al (2018) Poly-GR dipeptide repeat polymers correlate with neurodegeneration and clinicopathological subtypes in C9ORF72-related brain disease. Acta Neuropathol Commun 6:63. https:\/\/doi.org\/10.1186\/s40478-018-0564-7","journal-title":"Acta Neuropathol Commun"},{"key":"2216_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00401-019-02084-y","volume":"138","author":"PJ Sampognaro","year":"2019","unstructured":"Sampognaro PJ, Vatsavayai SC, Cosme CG, Hwang JHL, Nolan A, Huang EJ et al (2019) C9orf72-specific phenomena associated with frontotemporal dementia and gastrointestinal symptoms in the absence of TDP-43 aggregation. Acta Neuropathol 138:1093\u20131097. https:\/\/doi.org\/10.1007\/s00401-019-02084-y","journal-title":"Acta Neuropathol"},{"key":"2216_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00401-015-1450-z","volume":"130","author":"MH Schludi","year":"2015","unstructured":"Schludi MH, May S, Gr\u00e4sser FA, Rentzsch K, Kremmer E, K\u00fcpper C, German Consortium for Frontotemporal Lobar Degeneration, Bavarian Brain Banking Alliance et al (2015) Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol 130:537\u2013555. https:\/\/doi.org\/10.1007\/s00401-015-1450-z","journal-title":"Acta Neuropathol"},{"key":"2216_CR24","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1093\/brain\/aww250","volume":"139","author":"SC Vatsavayai","year":"2016","unstructured":"Vatsavayai SC, Yoon SJ, Gardner RC, Gendron TF, Vargas JNS, Trujillo A et al (2016) Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain 139:3202\u20133216. https:\/\/doi.org\/10.1093\/brain\/aww250","journal-title":"Brain"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-020-02216-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-020-02216-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-020-02216-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T23:10:42Z","timestamp":1630278642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-020-02216-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,30]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2216"],"URL":"https:\/\/doi.org\/10.1007\/s00401-020-02216-9","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,30]]},"assertion":[{"value":"16 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MO gave scientific advice for Roche (Switzerland), Biogen (USA) and Axon. ACL serves on the Advisory Board of Roche Pharma (Switzerland) and Biogen (USA), and on the data and safety monitoring board of Zeneus pharma (UK). ACL received consulting fees from AB-Science (FRA), Desitin (UK), Novartis (Switzerland) and Teva (ISR). RV\u2019s institution has a clinical trial agreement (RV as PI) with AbbVie (USA), Biogen (USA), Genentech (USA), Novartis (Switzerland), and Roche (Switzerland). PVD participated in advisory board meetings for Genzyme (USA), Pfizer (USA), Biogen (USA), Cytokinetics (USA), Mitsubishi Tanabe (Japan), CSL Behring (USA) and Alexion Pharmaceuticals (USA). DRT received speaker honorary from Novartis Pharma AG (Switzerland) and Biogen (USA), travel reimbursement from GE-Healthcare (UK) and UCB (BE), and collaborated with Novartis Pharma AG (Switzerland), Probiodrug (Germany), GE-Healthcare (UK), and Janssen Pharmaceutical Companies (Belgium).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}